<DOC>
	<DOCNO>NCT01326533</DOCNO>
	<brief_summary>The purpose study determine short-term effect antimalarial medication , hydroxychloroquine ( HCQ ) , compare placebo use frequently sample intravenous glucose tolerance testing ( FSIGTT ) methodology study change insulin secretion glucose tolerance subject risk develop Type 2 diabetes .</brief_summary>
	<brief_title>Reducing Risk Type 2 Diabetes : Hydroxychloroquine Use Pre-Diabetes</brief_title>
	<detailed_description>Diabetes approach epidemic proportion United States . This study evaluate mechanisms action generic drug may effect glucose metabolism .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>1 . Age &gt; = 18 , able provide inform consent 2 . Bodymass index great equal 25 3 . Presence least one indicator insulin resistance follow list : Family history Type 2 diabetes ( parent , sibling ) Fasting glucose 100 125 mg/dl Fasting serum insulin great equal 7uU/ml Personal history gestational diabetes 4 . Negative pregnancy test woman childbearing potential 1 . Diagnosis diabetes mellitus Type 1 Type 2 2 . Active autoimmune disease , chronic infection , current malignancy ( exclude basal cell carcinoma ) , active inflammatory state , opinion investigator , would affect insulin sensitivity 3 . Oral corticosteroid use prior six month , expectation need corticosteroid therapy upcoming six month 4 . Known allergy intolerance HCQ 5 . Known glucose6 phosphate dehydrogenase deficiency 6 . Known eye disease associate retinal pigmentation abnormality 7 . Known diabetic retinopathy require past plan laser therapy 8 . Inability comply visit schedule protocol requirement 9 . Inability manage take medication instruct 10 . Current planned pregnancy upcoming 12 month 11 . Inability unwillingness use reliable method contraception ( woman childbearing year , men , men 's partner childbearing potential ) , oral contraceptive pill , barrier method ( diaphragm condom spermicide ) , intrauterine device , depoprovera injection 3 month prior enrollment 12 . Anemia ( HGB &lt; 9 ) 13 . Any history bariatric ( weight loss ) surgery 14 . Current use medication Glucophage ( metformin ) 15 . Weight change 6 pound past 4 week 16 . Any underlying concomitant condition , opinion principal investigator , could confound result study put subject undue risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>pre-diabetes</keyword>
	<keyword>hydroxychloroquine</keyword>
	<keyword>frequently sample intravenous glucose tolerance test</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>glucose tolerance</keyword>
</DOC>